(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
Star0
Identification
- Generic Name
- (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one
- DrugBank Accession Number
- DB07757
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 335.236
Monoisotopic: 334.056842499 - Chemical Formula
- C17H19BrO2
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UEstrogen receptor beta Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as fluorenes. These are compounds containing a fluorene moiety, which consists of two benzene rings connected through either a cyclopentane, cyclopentene, or cyclopenta-1,3-diene.
- Kingdom
- Organic compounds
- Super Class
- Benzenoids
- Class
- Fluorenes
- Sub Class
- Not Available
- Direct Parent
- Fluorenes
- Alternative Parents
- Indanes / Cyclohexenones / 1-hydroxy-2-unsubstituted benzenoids / Alpha-haloketones / Vinyl bromides / Bromoalkenes / Organobromides / Organic oxides / Hydrocarbon derivatives
- Substituents
- 1-hydroxy-2-unsubstituted benzenoid / Alpha-haloketone / Aromatic homopolycyclic compound / Bromoalkene / Carbonyl group / Cyclic ketone / Cyclohexenone / Fluorene / Haloalkene / Hydrocarbon derivative
- Molecular Framework
- Aromatic homopolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- FTEBGBCQCYMDPH-KRWDZBQOSA-N
- InChI
- InChI=1S/C17H19BrO2/c1-2-3-7-17-8-6-14(20)16(18)15(17)13-5-4-12(19)9-11(13)10-17/h4-5,9,19H,2-3,6-8,10H2,1H3/t17-/m0/s1
- IUPAC Name
- (9aS)-4-bromo-9a-butyl-7-hydroxy-2,3,9,9a-tetrahydro-1H-fluoren-3-one
- SMILES
- CCCC[C@]12CC3=CC(O)=CC=C3C1=C(Br)C(=O)CC2
References
- General References
- Not Available
- External Links
- PubChem Compound
- 11987846
- PubChem Substance
- 99444228
- ChemSpider
- 10160319
- BindingDB
- 50185849
- ChEMBL
- CHEMBL211614
- ZINC
- ZINC000016052063
- PDBe Ligand
- FBR
- PDB Entries
- 2giu
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.00706 mg/mL ALOGPS logP 5.1 ALOGPS logP 4.78 Chemaxon logS -4.7 ALOGPS pKa (Strongest Acidic) 8.93 Chemaxon pKa (Strongest Basic) -6.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 37.3 Å2 Chemaxon Rotatable Bond Count 3 Chemaxon Refractivity 84.77 m3·mol-1 Chemaxon Polarizability 32.77 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9287 Caco-2 permeable + 0.7507 P-glycoprotein substrate Substrate 0.7203 P-glycoprotein inhibitor I Non-inhibitor 0.7791 P-glycoprotein inhibitor II Non-inhibitor 0.77 Renal organic cation transporter Non-inhibitor 0.7205 CYP450 2C9 substrate Non-substrate 0.7832 CYP450 2D6 substrate Non-substrate 0.8812 CYP450 3A4 substrate Substrate 0.7093 CYP450 1A2 substrate Inhibitor 0.599 CYP450 2C9 inhibitor Inhibitor 0.5304 CYP450 2D6 inhibitor Non-inhibitor 0.8392 CYP450 2C19 inhibitor Inhibitor 0.6207 CYP450 3A4 inhibitor Non-inhibitor 0.6267 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7781 Ames test Non AMES toxic 0.8342 Carcinogenicity Non-carcinogens 0.9054 Biodegradation Not ready biodegradable 0.9953 Rat acute toxicity 2.1719 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7106 hERG inhibition (predictor II) Non-inhibitor 0.6242
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-056r-7295000000-d309102490a66b325000 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-0009000000-2d2a494f17c7985a752e Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0009000000-bb1f1ee30a379115ff54 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-0097000000-20ab32b53d60d4a4cc1f Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0009000000-cdbdd3ed5ca423357492 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-076u-0590000000-37ab2218cd1f2030e6dd Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-004i-9031000000-1e27254517b5b3c8876e Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 173.31697 predictedDeepCCS 1.0 (2019) [M+H]+ 175.67497 predictedDeepCCS 1.0 (2019) [M+Na]+ 181.76811 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsEstrogen receptor beta
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent m...
- Gene Name
- ESR2
- Uniprot ID
- Q92731
- Uniprot Name
- Estrogen receptor beta
- Molecular Weight
- 59215.765 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52